Cipla 125 Pill: pink, capsule/oblong, 16mm
The pill with imprint Cipla 125 (Pink, Capsule/Oblong, 16mm) has been identified as Topiramate 200 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for Cipla 125
Topiramate
- Imprint
- Cipla 125
- Strength
- 200 mg
- Color
- Pink
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0125
- Inactive Ingredients
-
lactose monohydrate,
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (3 mPa.s),
magnesium stearate,
polyethylene glycol 400,
polysorbate 80,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide,
microcrystalline cellulose,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "Cipla 125"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,342)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.